期刊文献+

PET/CT复合功能成像系统诊断乳腺癌 被引量:3

Qualitative analysis of FDG uptake and blood perfusion by PET/CT in breast cancer
原文传递
导出
摘要 目的评价18F-FDG PET复合CT灌注成像诊断原发性乳腺癌的价值。方法对33例疑似乳腺癌病人行CT灌注成像和PET成像检查,并进行真实性和可靠性评价。结果27例乳房肿块经病理证实为乳腺癌。PET/CT诊断乳腺癌的敏感度、特异度和精确度分别为92.6%、100%、93.9%。结论PET/CT诊断乳腺癌有着较高的敏感度、特异度和可靠性,作为一种非侵袭性检查方法,可提供乳腺癌在活体内的代谢和血流灌注信息。 Objective To evaluate the use of PET/CT in the diagnosis of breast cancer. Methods In this study ,33 patients with suspicious breast tumor underwent PET/CT imaging. The images of the breast were analyzed for qualitative assessment of increased tracer uptake and blood perfusion with PET/CT. Results Among 27 cases with pathology proved breast cancer, 25 was judged as PET/CT positive,2 was false-negative. Sensitivity, specificity and accuracy of PET/CT in identifying breast cancer were 92.6% , 100% ,93.9%. Conclusion PET/CT is a reliable and sensitive measure in the diagnosis of breast cancer in vivo.
出处 《中华普通外科杂志》 CSCD 北大核心 2005年第11期718-720,共3页 Chinese Journal of General Surgery
关键词 乳腺肿瘤 体层摄影术 发射型计算机 Breast neoplasms Tomography, positron emission
  • 相关文献

参考文献7

  • 1Wang Y, Yu J, Liu J, et al. PET-CT in the diagnosis of both primary breast cancer and axillary lymph node metastasis: initial experience.lnt J Radiat Oncol Biol Phys,2003, 57:362s-362s.
  • 2Miles KA. Functional computed tomography in oncology. Eur J Cancer, 2002,38 : 2079 -2084.
  • 3Avril N, Rose CA, Schelling M, et al. Breast imaging positron emission tomography and fluoro 18 fluorodeoxyglucose: use and limitations. J Clin Oncol, 2000,18:3495-3502.
  • 4Avril N, Dose J, Janicke F, et al. Metabolic characterization of breast tumor with positron emission tomography using F-18 fluorodexyglucose. J Clin Oncol, 1996,14 : 1848-1857.
  • 5Bird RE, Wallace TW, Yankaskas BC. Analysis of cancer missed at screening mammography. Radiology, 1992,184:613-617.
  • 6Fisch U, Kopka L, Grabbe E. Breast carcinoma : effect of preoperative contrast-enhanced MR imaging on the therapeutic approach.Radiology, 1999,213:881-888.
  • 7Schirrmeister H, Kuhn T,Gubi manna,et al. Fluorine-18-2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer:comparison with the standard staging procedures. Eur J Nucl Med,2001,28:351-358.

同被引文献13

  • 1海健,毛杰,刘少华,唐利立,申正堂.隐匿性乳腺癌的诊断和治疗(附24例报告)[J].中国医师杂志,2006,8(3):386-387. 被引量:3
  • 2Owen H W,Dockerty M S,Gray H K.Occult Carcinoma of the breast [J].Surg Gynecl Obstet,1954,98(3):302-308.
  • 3M M,RiveraD- E,TarzJJ,etal.Oectflt Primary adenocareinoma with auxillary Sury ,1986,152(1):43-47.
  • 4Brem R F,Rapelyea J A,Lisman G.Occult Breast cancer, scinti mammography with high-resolution breast-specific gamma canera women at high risk for breast canner .Radiology,2005,237 (1):274- 280.
  • 5Pancivli A,Polito R,Masini V.Mucinous metastases from occult breast carcinoma.rays,205,30(1):11-17.
  • 6Caumo F,Gaioni M B, BonettiF. Occultinflammatory breast canner: review of clinical,mammographic,VS and pathologic signs.kadiol Med (Torino),2005,109(4):308-320.
  • 7Jackson B,Scott Conner C,Moulder J.Axillary metastasis from occult breast carcinoma :Diagnosis and managment[J].Am Stay ,1995,61 (5):431-434.
  • 8Vlastos G jean ME,Mirza AN.et al.Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases[J].Ann Sury Oncol 2001,8(5):425-431.
  • 9赵明一,肖晖,高峰.隐匿性乳腺癌12例临床分析[J].国际外科学杂志,2009,36(1):16-19. 被引量:3
  • 10马广义,袁卫国,崔艳超.隐匿性乳腺癌45例诊治体会[J].内蒙古中医药,2010,29(4):92-93. 被引量:4

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部